SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Neurobiological Tech (NTII) -- Ignore unavailable to you. Want to Upgrade?

To: keokalani'nui who wrote (1460)12/4/2007 1:05:45 PM
From: Steve Lokness  Read Replies (1) | Respond to of 1494
 
I bet recent investors hang around no longer than 8 months.

Do you say this even if Viprinex is a commercial success?

steve



To: keokalani'nui who wrote (1460)12/4/2007 10:50:41 PM
From: rkrw  Read Replies (2) | Respond to of 1494
 
I think it will be tough for the buyers to get out. Too thinly traded and they hold over 80% of the stock. But they have a long time to work it.

I don't know if anyone else noticed but Celtic Pharma put out a PR this morning, titled Xerecept Update but pulled it.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News